January 28, 2023
Life Care News
23andMe to Report FY2023 Third Quarter Financial Results
Continue reading 23andMe to Report FY2023 Third Quarter Financial Results at Life Care News.... See more »
Foundation Medicine: Foundation Medicine Announces Strategic Collaboration with Arvinas
CAMBRIDGE, Mass.-(BUSINESS WIRE)-Today Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced a collaboration with Arvinas, Inc., to... Read MoreThe post Foundation Medicine Announces Strategic Collaboration with Arvinas appeared first on citybiz.
Read full article »
January 28, 2023
Medthority
FDA appproves Keytruda for adjuvant treatment following surgical resection and chemotherapy for NSCLC.- Merck Inc.,
Merck Inc., known as MSD outside of the United States and Canada, announced that the FDA has approved... See more »
January 28, 2023
Life Care News
23andMe to Report FY2023 Third Quarter Financial Results
Continue reading 23andMe to Report FY2023 Third Quarter Financial Results at Life Care News.... See more »
January 28, 2023
Medthority
FDA appproves Keytruda for adjuvant treatment following surgical resection and chemotherapy for NSCLC.- Merck Inc.,
Merck Inc., known as MSD outside of the United States and Canada, announced that the FDA has approved... See more »
Foundation Medicine is a Massachusetts-based biotechnology company that provides genomic profiling assays and clinical trail matching solutions for oncology research centers.
Read more